Tampa, Florida – The Tampa Bay area is grappling with a concerning trend as consumers are able to easily purchase a substance that resembles a potent opioid without the need for a prescription. This substance, known as 7-hydroxymitragynine or 7-OH, is found in products that are largely unregulated and have attracted the attention of experts warning about its potential dangers to public health. While bills aimed at regulating the sale of these products have failed to gain traction in Tallahassee, calls for intervention are growing louder as concerns mount.
Scientists have pointed out that 7-OH, which is derived from the kratom plant, poses a serious risk due to its potency compared to traditional kratom leaf products. The rise in availability of 7-OH products across Florida has prompted lawmakers to revisit the issue, with proposals to ban pure 7-hydroxymitragynine products gaining momentum in the state legislature. Concerns have been raised about the potential for these products to fuel another wave of opioid-related issues in society.
Amidst these developments, the debate over the safety and regulation of 7-OH products continues to intensify. While some industry groups argue for the safety of these products, leading kratom researchers have expressed reservations, citing the lack of studies demonstrating their safety for human consumption. The FDA’s lack of clear guidelines on the regulation of these products has further complicated the situation, leaving consumers and lawmakers in a state of uncertainty.
As the discussion around 7-OH products evolves, there is a growing consensus among experts and industry stakeholders that stricter regulations are needed to ensure consumer safety. Efforts to curb the sale of pure 7-hydroxymitragynine products are gaining traction in Florida and other states, reflecting a broader push to address the challenges posed by these novel substances. With the Senate set to consider a bill on the issue, the fate of 7-OH products in the Tampa Bay region remains uncertain, but the urgency for action is palpable.









Lord Abbett High Yield Fund Q4 2025 Commentary: What Investors Need to Know for a Profitable Future!
Jersey City, New Jersey—In the closing quarters of 2025, Lord Abbett High Yield Fund navigated a challenging investment landscape, marked by evolving interest rates and shifting economic indicators. Analysts noted that despite initial obstacles, investors were encouraged by the fund’s strategic allocation and management decisions, which positioned it favorably amidst market uncertainty. The fund’s performance during the fourth quarter reflected a cautious but calculated approach to high-yield debt. With inflationary pressures beginning to stabilize, the fund’s managers focused on identifying opportunities in sectors that showed ... Read more